Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
T(H)17 lymphocytes appear to be essential in the pathogenesis of numerous inflammatory diseases. We demonstrate here the expression of IL-17 and IL-22 receptors on blood-brain barrier endothelial cells (BBB-ECs) in multiple sclerosis lesions, and show that IL-17 and IL-22 disrupt BBB tight junctions in vitro and in vivo. Furthermore, T(H)17 lymphocytes transmigrate efficiently across BBB-ECs, highly express granzyme B, kill human neurons and promote central nervous system inflammation through CD4+ lymphocyte recruitment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [128]
The cited source says what the claim attributes to it.
In the citing paper
“a subset of CD4+ T cells that is a major contributor to the pathogenicity of several inflammatory and autoimmune conditions (9–11)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“inflammatory subtypes of T cells, particularly Th17 cells, are clearly deleterious in diseases such as multiple sclerosis (9–11, 24)”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Th17 cells are deleterious to the CNS”
From Inflammatory T helper 17 cells promote depression-like behavior in mice (2013) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P., Kasman, I., Eastham-Anderson, J., Wu, J., & Ouyang, W. (2007) · Nature · doi:10.1038/nature05505 · Cited by 1,862
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis
Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H., & Kuchroo, V. K. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031819 · Cited by 488
Wosik, K., Cayrol, R., Dodelet-Devillers, A., Berthelet, F., Bernard, M., Moumdjian, R., Bouthillier, A., Reudelhuber, T. L., & Prat, A. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.2088-07.2007 · Cited by 259
Self-citationExpression and regulation of IL-22 in the IL-17-producing CD4+ T lymphocytes
Chung, Y., Yang, X., Chang, S. H., Ma, L., Tian, Q., & Dong, C. (2006) · Cell Research · doi:10.1038/sj.cr.7310106 · Cited by 231
Cited by
Items 901–1,000 of 1,003
Neurovascular Coupling in Hypertension Is Impaired by IL-17A through Oxidative Stress
Youwakim, J., Vallerand, D., & Girouard, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043959 · Cited by 26
Chen, H., Liao, Y., Zhang, X., Shen, H., Shang, D., He, Z., Zhou, W., & Song, Z. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02790-1 · Cited by 29
Curcumin as a regulator of Th17 cells: Unveiling the mechanisms
Ghoushi, E., Poudineh, M., Parsamanesh, N., Jamialahmadi, T., & Sahebkar, A. (2024) · Food Chemistry Molecular Sciences · doi:10.1016/j.fochms.2024.100198 · Cited by 32
“This enhanced migratory ability is facilitated by the expression of IL-17R and IL-22R on BBB endothelial cells (Kebir et al., 2007).”
BackgroundCCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis
Khaiboullina, S. F., Gumerova, A. R., Khafizova, I. F., Martynova, E. V., Lombardi, V. C., Bellusci, S., & Rizvanov, A. A. (2015) · BioMed Research International · doi:10.1155/2015/189638 · Cited by 24
Citalopram suppresses thymocyte cytokine production
Shenoy, A. R., Dehmel, T., Stettner, M., Kremer, D., Kieseier, B. C., Hartung, H. P., & Hofstetter, H. H. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.06.006 · Cited by 26
Goertsches, R. H., Zettl, U. K., & Hecker, M. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.190 · Cited by 25
Abdurasulova, I. N., Matsulevich, A. V., Тарасова, Е. А., Kudryavtsev, I. V., Серебрякова, М. К., Ермоленко, Е. И., Бисага, Г. Н., Клименко, В. М., & Suvorov, A. N. (2016) · Beneficial Microbes · doi:10.3920/bm2016.0018 · Cited by 27
Seki, S. M., Stevenson, M. E., Rosen, A. M., Arandjelovic, S., Gemta, L. F., Bullock, T. N. J., & Gaultier, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1600825 · Cited by 24
“Strikingly, production of IL-17A, another cytokine associated with autoimmune demyelination (30, 31), was largely refractory to 3-BrPa treatment (Fig.”
BackgroundPeón, A. N., Ledesma‐Soto, Y., Olguín, J. E., Bautista-Donis, M., Sciutto, E., & Terrazas, L. I. (2017) · Mediators of Inflammation · doi:10.1155/2017/8494572 · Cited by 26
“For instance, IL-17A downregulates the expression of the tight-junction proteins, increasing the blood-brain barrier (BBB) permeability and thus facilitate inflammatory cell infiltration into the CNS [31].”
BackgroundKilling effect of methionine enkephalin on melanoma in vivo and in vitro
Wang, D.-M., Jiao, X., Plotnikoff, N. P., Griffin, N., Qi, R., Gao, X., & Shan, F. (2017) · Oncology Reports · doi:10.3892/or.2017.5918 · Cited by 25
“Th1 cells are often considered as pro-inflammatory factors, which could respond to IL-12, produce IFN-γ and enhance the pathway of CD4+ T cell proliferation and inflammation (34,35).”
BackgroundDai, Q., Li, S., Liu, T., Zheng, J., Han, S., Qu, A., & Li, J. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28429 · Cited by 24
Regulatory Properties of Copolymer I in Th17 Differentiation by Altering STAT3 Phosphorylation
Chen, C., Liu, X., Wan, B., & Zhang, J. Z. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900193 · Cited by 25
“These studies strongly support the pathogenic role of Th17 in autoimmune disease, including MS (6, 7).”
ResultInterleukin-17 bei chronisch-entzündlichen und autoimmunen Erkrankungen
Müller, U., & Lamprecht, P. (2007) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-007-0236-7 · Cited by 24
Nakajima, A., Yanagimura, F., Saji, E., Shimizu, H., Toyoshima, Y., Yanagawa, K., Arakawa, M., Hokari, M., Yokoseki, A., Wakasugi, T., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02725-x · Cited by 29
“…T cells)-MCAM (on BBB-endothelial cells [ECs]) interactions or heterophilic interactions between MCAM (on T cells) and other ligands (e.g., laminin 411; on BBB-ECs) in experimental autoimmune encephalomyelitis (EAE) animal models or in patients with multiple sclerosis (MS) [6, 10, 17, 35, 42, 43].”
Prognostic value of natural killer cell/T cell ratios for disease activity in multiple sclerosis
Mimpen, M., Muris, A., Rolf, L., Gerlach, O. H. H., Kühle, J., Hupperts, R., Smolders, J., & Damoiseaux, J. G. M. C. (2020) · European Journal of Neurology · doi:10.1111/ene.14680 · Cited by 25
Metabolic Sex Dimorphism of the Brain at the Gene, Cell, and Tissue Level
Lee, J. W., Profant, M. R., & Wang, C. (2022) · The Journal of Immunology · doi:10.4049/jimmunol.2100853 · Cited by 26
“Conventional CD41 T cells, particularly Th17 cells, are potent inducers of neuroinflammation due to their ability to efficiently migrate through the blood-brain barrier through production of IL-17 and IL-22 (49).”
BackgroundDissection of multiple sclerosis genetics identifies B and CD4+ T cells as driver cell subsets
Guo, M. H., Sama, P., LaBarre, B. A., Lokhande, H. A., Balibalos, J., Chu, C., Du, X., Kheradpour, P., Kim, C. C., Oniskey, T. K., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02694-y · Cited by 24
Advances in Potential Cerebrospinal Fluid Biomarkers for Autoimmune Encephalitis: A Review
Zhang, S., Mao, C., Li, X., Miao, W., & Teng, J. (2022) · Frontiers in Neurology · doi:10.3389/fneur.2022.746653 · Cited by 27
Alotaibi, M. R., Alaqil, F. A., Alqahtani, F., Alanazi, M., Nadeem, A., Ahmad, S. F., Lapresa, R., Alharbi, M., Alshammari, A., Alotaibi, M., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.891593 · Cited by 25
“, 2020), which is considered as a neurotoxic cytokine (Li et al., 2007; Kebir et al., 2007; Bǎlaşa et al., 2013; Debnath and Berk, 2014).”
BackgroundZong, B., Yu, F., Zhang, X., Zhao, W., Li, S., & Li, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1260663 · Cited by 25
Integrin α3 promotes T H 17 cell polarization and extravasation during autoimmune neuroinflammation
Park, E., Barclay, W. E., Barrera, A., Liao, T.-C., Salzler, H. R., Reddy, T. E., Shinohara, M. L., & Ciofani, M. (2023) · Science Immunology · doi:10.1126/sciimmunol.adg7597 · Cited by 23
Microbes and Mental Illness: Past, Present, and Future
Bransfield, R. C., Mao, C., & Greenberg, R. (2023) · Healthcare · doi:10.3390/healthcare12010083 · Cited by 30
“In a murine model of PANDAS, evidence supports the action of Th17 cells releasing the cytokine IL-17A, which is thought to play an important role in the entry of immune system cells into the CNS [494].”
BackgroundPravica, V., Popadic, D. M., Savić, E., Marković, M., Drulovic, J. S., & Mostarica‐Stojković, M. (2012) · Immunologic Research · doi:10.1007/s12026-012-8273-y · Cited by 25
Granzymes A and B levels in serum of patients with amyotrophic lateral sclerosis
Iłżecka, J. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.02.006 · Cited by 24
Multiple Sclerosis Therapies: Molecular Mechanisms and Future
da Fontoura, P. P., & Garren, H. (2009) · Results and problems in cell differentiation · doi:10.1007/400_2010_36 · Cited by 25
“These cells may have important roles in disease progression and the generation of parenchymal lesions; recently, human Th17 cells were shown to be present in MS plaques, to have increased migratory capacity to the CNS, and to express granzyme B ( Kebir et al. 2007 ).”
BackgroundPolymorphisms of IL-17 and ICAM-1 and their expression in Guillain–Barré syndrome
Kharwar, N. K., Prasad, K. N., Singh, K., Paliwal, V. K., & Modi, D. R. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1231186 · Cited by 27
“homology with IL-17 [5] and Human Th17 cells could involve in disruption of blood–brain barrier, stimulating the inflammation, macrophage activation, chemotaxis of neutrophils and myelin damage [6,7].”
BackgroundParastouei, K., Mirshafiey, A., Eshraghian, M. R., Shiri‐Shahsavar, M. R., Solaymani‐Mohammadi, F., Chahardoli, R., Alvandi, E., & Saboor-Yaraghi, A. A. (2016) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1263039 · Cited by 24
Laquinimod enhances central nervous system barrier functions
Lühder, F., Kébir, H., Odoardi, F., Litke, T., Sonneck, M., Alvarez, J. I., Winchenbach, J., Eckert, N., Hayardeny, L., Sorani, E., et al. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.02.002 · Cited by 25
“…immune organs during the course of viral or bacterial infections, and thereby gain the ability to overcome the blood brain barrier (BBB), which normally protects the CNS against the entry of circulating immune cells and soluble factors (Kebir et al., 2007; Kebir et al., 2009; Alvarez et al., 2013).”
BackgroundSelf-citationBiomarkers in Multiple Sclerosis
Martinꝉ, R., Bielekova, B., Hohlfeld, R., & Utz, U. (2006) · Disease Markers · doi:10.1155/2006/508354 · Cited by 26
Making Connections: Guidance Cues and Receptors at Nonneural Cell–Cell Junctions
Beamish, I. V., Hinck, L., & Kennedy, T. E. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a029165 · Cited by 23
“The BBB regulates the passage ofmolecules and cells between the blood and the central nervous system and may become compromised during cases of inflammatory brain pathology such as multiple sclerosis and stroke (Unterberg et al. 2004; Kebir et al. 2007).”
BackgroundThomas, O. G., & Olsson, T. P. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1304281 · Cited by 25
Regulatory Roles of Bone in Neurodegenerative Diseases
Yu, Z., Ling, Z., Lin, L., Zhao, J. X., Chen, X., Xu, P., & Zou, X. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.610581 · Cited by 24
Parkinson’s Disease and the Metal–Microbiome–Gut–Brain Axis: A Systems Toxicology Approach
Forero-Rodríguez, L. J., Josephs‐Spaulding, J., Flor, S., Pinzón, A. M., & Kaleta, C. (2021) · Antioxidants · doi:10.3390/antiox11010071 · Cited by 26
Jamann, H., Cui, Q., Desu, H. L., Pernin, F., Tastet, O., Halaweh, A., Farzam‐kia, N., Mamane, V. H., Ouédraogo, O., Cleret‐Buhot, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.850616 · Cited by 28
“Altogether, these data revealed that RNA expression of proinflammatory cytokines and importantly of pro-apoptotic serin protease granzyme B (9) is induced in human Th17-polarized cells upon direct contact with primary human OLs.”
BackgroundResultInfluentialSelf-citationJanoschka, C., Lindner, M., Koppers, N., Starost, L. J., Liebmann, M., Eschborn, M., Schneider‐Hohendorf, T., Windener, F., Schafflick, D., Fleck, A.-K., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2209944120 · Cited by 24
“In the light of the known properties of human Th17 cells to alter brain EC functions (28), we wondered whether long-term NAT treatment-associated increase in pathogenicity might affect brain microvascular endothelial barrier properties.”
InfluentialDifferentiation and regulation of CD4+ T cell subsets in Parkinson’s disease
Sun, X., Gu, R., & Bai, J. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05402-0 · Cited by 26
“Kebir et al. found that IL-17 and IL-22 disrupted the integrity of the BBB and promoted CD4 + lymphocyte migration [258 ].”
BackgroundDhib-Jalbut, S. S., Sumandeep, S., Valenzuela, R. M., Ito, K., Patel, P., & Rametta, M. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.08.012 · Cited by 23
“Nevertheless, Th17 cells are pro-inflammatory as they have been shown to damage the BBB (Kebir et al., 2007) and also stimulate GM-CSF producing cells (Codarri et al.”
Cristofanilli, M., Rosenthal, H., Cymring, B., Gratch, D., Pagano, B., Xie, B., & Sadiq, S. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.020 · Cited by 23
Cordero‐Coma, M., Calleja, S., Llorente, M., Rodríguez, E., Franco, M. J., & de Morales, J. M. G. R. (2013) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2013.770888 · Cited by 22
“Raised TNFa, IL-1b, VEGF, and, more recently, IL-17 and IL-22 serum levels have been related to blood–retinal barrier breakdown.(12) Raised serum levels of TNFa,(13) IL-6,(14) IL-8,(15) IL-17,(16) IL-21,(17) and IL-23,(16,18) have been described to correlate with ocular inflammatory activity in different uveitis clin-”
BackgroundTakeichi, N., Yanagisawa, S., Kaneyama, T., Yagita∥, H., Jin, Y.-H., Kim, B. S., & Koh, C. S. (2010) · International Immunology · doi:10.1093/intimm/dxq059 · Cited by 22
Fattahi, M. J., Ahmadi, H., Jafarnezhad‐Ansariha, F., Mortazavi‐Jahromi, S. S., Rehm, B. H. A., Cuzzocrea, S., Matsuo, H., & Mirshafiey, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.059 · Cited by 26
Hu, Q., Shi, J., Zhang, J., Wang, Y., Guo, Y., & Zhang, Z. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100032 · Cited by 24
Liu, H., Shi, Z., Fan, D., Zhang, S., Wu, L., Lu, K., Yang, S., Li, W., Kang, J., Li, C., et al. (2022) · Molecular Immunology · doi:10.1016/j.molimm.2022.02.004 · Cited by 22
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Marti, A., Mirabella, M., Tonali, P. A., & Batocchi, A. P. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.003 · Cited by 23
“Therefore in converted CIS patients during remission, the CD4+ T cells expressing high levels of pSTAT3 might produce IL17 rather than IL10 and might be able to cross the blood–brain barrier and to enter into the brain (Kebir et al., 2007).”
BackgroundChung, C., & Liao, F. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0536-4 · Cited by 26
“In accord with these findings, studies in human patients have shown that Th17 cells are involved in MS [13, 14].”
ResultThe role of T-lymphocytes in central nervous system diseases
Shen, J., Bian, N., Zhao, L., & Wei, J. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110904 · Cited by 22
“Th17 cells also enhance granzyme B production, accelerating neuronal death (Kebir et al., 2007), and IL-17 increases NADPH oxidase and reactive oxygen production, which can alter endothelial cell morphology, cause endothelial cell contraction, downregulate tight junction proteins (Huppert et al.,…”
BackgroundThe role of reactive oxygen species in the regulation of the blood-brain barrier
Shuvalova, M. L., Dmitrieva, A., Belousov, V. V., & Nosov, G. (2024) · Tissue Barriers · doi:10.1080/21688370.2024.2361202 · Cited by 26
“186,187 PD is characterized by the selective damage of dopaminergic neurons in the substantia nigra and a decrease in dopamine levels in the striatum.”
Dias, A. T., de Castro, S. B. R., Alves, C. C. D. S., Evangelista, M. G., da Silva, L. C., Faza, D. R. D. L. R., Machado, M. A., Juliano, M. A., & Ferreira, A. P. (2018) · Inflammation Research · doi:10.1007/s00011-018-1146-7 · Cited by 21
Risks and outcomes of pregnancy in neuromyelitis optica spectrum disorder: A comprehensive review
Siriratnam, P., Huda, S., Butzkueven, H., van der Walt, A., Jokubaitis, V., & Monif, M. (2023) · Autoimmunity Reviews · doi:10.1016/j.autrev.2023.103499 · Cited by 21
Leonardi, L., Perna, C., Bernabei, I., Fiore, M., Ma, M., Frankovich, J., Tarani, L., & Spalice, A. (2024) · Children · doi:10.3390/children11091043 · Cited by 47
“Moreover, this amplifies the production of reactive oxygen species (ROS) by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase and xanthine oxidase, as indicated in vivo and in vitro studies in human brain-derived endothelial cells [55,56].”
BackgroundStudying the Human Immunome: The Complexity of Comprehensive Leukocyte Immunophenotyping
Biancotto, A., & McCoy, J. P. (2013) · Current topics in microbiology and immunology · doi:10.1007/82_2013_336 · Cited by 21
“CD146 appears to be involved in the extravasation and migration of these cells, and data suggest that Th17 cells are important in a number of autoimmune diseases (Amadi-Obi et al. 2007; Kebir et al. 2007; Brucklacher-Waldert et al. 2009; Kleinschek et al. 2009; Dagur et al. 2011).”
BackgroundHematopoietic stem cell transplantation in multiple sclerosis
Karussis, D. M., Petrou, P., Vourka-Karussis, U., & Kassis, I. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.36 · Cited by 23
Pathogenese der Psoriasis vulgaris
Schäkel, K., Schön, M. P., & Ghoreschi, K. (2016) · Der Hautarzt · doi:10.1007/s00105-016-3800-8 · Cited by 33
He, J., Sun, F., Wang, Y., Luo, X., Peng, L., Zhou, J., Zhu, D., Li, Z., & Yang, H. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.07.017 · Cited by 23
“…severity of inflammatory response in vivo and that IL-17 induces blood–brain barrier (BBB) disruption and promotes neuronal injury through an IL-17/IL-17R combination in multiple sclerosis and ischemic brain injury (Kebir et al., 2007; Kolls and Linden, 2004; Wang et al., 2009; Xu and Cao, 2010).”
BackgroundFournier, C. N., Houser, M. C., Tansey, M. G., Glass, J. D., & Hertzberg, V. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.007 · Cited by 24
Madhu, K., Prakash, T., & Maya, S. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.10.188 · Cited by 22
Abarca‐Zabalía, J., García, M. I., Ros, A. L., Marín‐Jiménez, I., Martínez‐Ginés, M. L., López-Cauce, B., Martin-Barbero, M. L., Salvador‐Martín, S., Sanjurjo‐Sáez, M., García‐Domínguez, J. M., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020676 · Cited by 23
“Th17 cells promote blood-brain barrier disruption, thus altering traffic and inducing chronic inflammation, which in turn leads to the degradation of myelin sheaths and axonal injury [14].”
BackgroundTH17/Treg imbalance and IL-17A increase after severe aneurysmal subarachnoid hemorrhage
Moraes, L., Trías, N., Brugnini, A., Grille, P., Lens, D., Biestro, A., & Grille, S. (2020) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2020.577310 · Cited by 21
Endothelin regulates function of IL-17-producing T cell subset
Tanaka, K., Yoshioka, K., Tatsumi, K., Kimura, S., & Kasuya, Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.01.084 · Cited by 21
Potential role of Th17 cells in the pathogenesis of type 2 autoimmune pancreatitis
Loos, M., Lauffer, F., Schlitter, A. M., Kleeff, J. H., Friess, H., Klöppel, G., & Esposito, I. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1850-4 · Cited by 21
Sajja, R. K., Kaisar, M. A., Vijay, V., Desai, V. G., Prasad, S., & Cucullo, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-31137-7 · Cited by 24
Kant, R., Pasi, S., & Surolia, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02508 · Cited by 21
“For instance, autoreactive Th17 cells can migrate efficiently across the blood brain barrier (BBB) aided by the cytokines such as IL-17 and IL22, and cell surface receptor CCR6 (17, 18).”
BackgroundYu, Y., Weiss, R. M., & Wei, S. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.032533 · Cited by 21
“22 In a mouse model of experimental autoimmune encephalomyelitis, it was observed that IL-17A disrupts the BBB, potentially through the activation of an oxidative stress–induced endothelial contractile mechanism involving the downregulation of occludin and integral adhesion molecule-1 protein.”
Clinical significance of soluble adhesion molecules in anti‐ NMDAR encephalitis patients
Ding, Y., Yang, C.-J., Zhou, Z., Yu, P., Chen, J., Pan, S., Xu, H. M., Cai, Y. A., Ou, K., Xie, W., et al. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.740 · Cited by 25
“The compromise of blood-brain barrier (BBB) integrity is closely related to the progression of autoimmune diseases.(4,5) Adhesion molecules facilitate the process of leukocyte migration and further modulate the permeability of the BBB to immune cells.”
BackgroundBorgonetti, V., Sanna, M. D., Lucarini, L., & Galeotti, N. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00958-8 · Cited by 21
“Endothelial cells express IL-17 receptor, and IL-17 destroys the tight junctions of the BBB to facilitate the migration of CD4 T cells in humans and mice [49, 50].”
BackgroundComputational modeling of the immune response in multiple sclerosis using epimod framework
Pernice, S., Follia, L., Maglione, A., Pennisi, M. A., Pappalardo, F., Novelli, F., Clerico, M., Beccuti, M., Cordero, F., & Rolla, S. (2020) · BMC Bioinformatics · doi:10.1186/s12859-020-03823-9 · Cited by 20
The IL‐27/IL‐27R axis is altered in CD4+ and CD8+ T lymphocytes from multiple sclerosis patients
Clénet, M., Laurent, C., Lemaître, F., Farzam‐kia, N., Tastet, O., Devergne, O., Lahav, B., Girard, M., Duquette, P., Prat, A., et al. (2021) · Clinical & Translational Immunology · doi:10.1002/cti2.1262 · Cited by 20
Self-citationAlmeida, R., Ferreira, M. L. B., Sonon, P., Cordeiro, M., Sadissou, I., Diniz, G., Militão-Albuquerque, M. D. F. P., França, R. F. D. O., Donadi, E., & Lucena-Silva, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.582935 · Cited by 17
“IL-17 was reported to increase IL-6 and IL-8 production by BBB-endothelial cells (63), and it is also responsible for the high CSF levels of IL-6 and IL-8.”
BackgroundTsur, S. W., Zaher, E. A., Tsur, M., Kania, K., & Kalinowska, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083859 · Cited by 21
“Th-1 cells increase the expression of MHC molecules of cells in the CNS, thereby participating in direct killing of oligodendrocytes and activating microglia [8,9].”
BackgroundHoffman, K. R., Brownell, Z., Doyle, W. J., & Ochoa‐Repáraz, J. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102957 · Cited by 22
Butyrate promotes post-stroke outcomes in aged mice via interleukin-22
Chen, Z., Xin, L., Yang, L., Xu, M., Li, F. Y., Zhou, M., & Yan, T. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114351 · Cited by 23
COVID-19 and Multiple Sclerosis: A Complex Relationship Possibly Aggravated by Low Vitamin D Levels
de Souza, W. D. F., da Fonseca, D. M., & Sartori, A. (2023) · Cells · doi:10.3390/cells12050684 · Cited by 19
“Infected leukocytes could also pass through the blood–brain barrier (BBB), acting as a Trojan horse.”
BackgroundInfluentialThe development and benefits of metformin in various diseases
Dong, Y., Qi, Y., Jiang, H., Tian, M., Zhang, Y., Peng, C. S., Li, W.-C., Zhang, Y., Zhou, Y., Zang, Y., et al. (2023) · Frontiers of Medicine · doi:10.1007/s11684-023-0998-6 · Cited by 21
Kap, Y. S., van Meurs, M., van Driel, N., Koopman, G., Melief, M., Brok, H., Laman, J. D., & Hart, B. A. ‘. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.954123 · Cited by 20
“In MS, IL-17A may play a role in blood–brain barrier transmigration of inflammatory cells (Kebir et al. 2007).”
BackgroundRole of IL-17-producing lymphocytes in severity of multiple sclerosis upon natalizumab treatment
Bühler, U., Fleischer, V., Luessi, F., Rezk, A., Belikan, P., Graetz, C., Gollan, R., Wolf, C., Lutz, J., Bar‐Or, A., et al. (2016) · Multiple Sclerosis Journal · doi:10.1177/1352458516658559 · Cited by 20
Insights into the Role of Neuroinflammation in the Pathogenesis of Multiple Sclerosis
Al‐Badri, G., & Castorina, A. (2018) · Journal of Functional Morphology and Kinesiology · doi:10.3390/jfmk3010013 · Cited by 21
“Further studies have demonstrated associations between this specific T-cell phenotype and their acquired ability to reach the site of demyelination/inflammation [40,41].”
BackgroundHeras‐Garvin, A., Refolo, V., Reindl, M., Wenning, G. K., & Stefanova, N. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-1714-y · Cited by 21
Interleukin 22 is related to development and poor prognosis of hepatocellular carcinoma
Shi, J., Wang, Y., Wang, F., Zhu, Z., Gao, Y., Zhang, Q., & Zhi, D. (2020) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.01.009 · Cited by 21
Huard, A., Nam, H., Frank, A.-C., Sirait‐Fischer, E., Fuhrmann, D. C., Hofmann, M. C. J., Raue, R., Palmer, G., Brüne, B., de Bruin, N. M. W. J., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2000923 · Cited by 21
Maghzi, A., Borazanci, A., McGee, J. C., Alexander, J. S., Gonzalez‐Toledo, E., & Minagar, A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-384913-7.00001-0 · Cited by 24
Ruberto, S., Domínguez‐Mozo, M. I., García‐Martínez, M. Á., Cossu, D., Sechi, L. A., & Álvarez‐Lafuente, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1505239 · Cited by 21
“Additionally, IL-17A is known for promoting the migration of human CD4+ T-cells across the blood-brain barrier (40), potentially explaining the reduced CD4+ response observed in the peripheral blood of MS patients in this study.”
Wojciechowski, S., Virenque, A., Vihma, M., Galbardi, B., Rooney, E. J., Keuters, M. H., Antila, S., Koıstınaho, J., & Noè, F. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.559810 · Cited by 22
“A polarized Th1/Th17 response has been reported in CNS autoimmune diseases (64) and can enhance the cytotoxicity of CD8+ T cells (7, 12).”
BackgroundÁlvarez‐Sánchez, N., & Dunn, S. E. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_324 · Cited by 24
Review on theranostic and neuroprotective applications of nanotechnology in multiple sclerosis
Sharma, A., Sharma, N., Singh, S. K., & Dua, K. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104220 · Cited by 25
Ahmad, S. F., Ansari, M. A., Nadeem, A., Bakheet, S. A., Al‐Mazroua, H. A., Alomar, H. A., Al‐Hamamah, M. A., & Attia, S. M. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104658 · Cited by 20
Imitola, J., Hollingsworth, E. W., Watanabe, F., Olah, M., Elyaman, W., Starossom, S. C., Kivisäkk, P., & Khoury, S. J. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1156802 · Cited by 19
Sabat, R., Witte, E., Witte, K., & Wolk, K. (2012) · Springer eBooks · doi:10.1007/978-3-0348-0522-3_2 · Cited by 23
Holzer, U., Reinhardt, K., Lang, P., Handgretinger, R., & Fischer, N. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.02.002 · Cited by 19
The IL17F and IL17RA Genetic Variants Increase Risk of Cerebral Malaria in Two African Populations
Marquet, S., Conte, I. L., Poudiougou, B., Argiro, L., Cabantous, S., Dessein, H., Burté, F., Oumar, A. A., Brown, B. J., Traore, A., et al. (2015) · Infection and Immunity · doi:10.1128/iai.00671-15 · Cited by 19
“Cytokines secreted by Th17 cells, including IL-17 and IL-22, may alter the permeability of the human BBB to soluble molecules and circulating CD4 lymphocytes (33).”
BackgroundZheng, X., Feng, L., Jiang, W., Wu, P., Liu, Y., Kuang, S., Tang, L., & Zhou, X. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.07.036 · Cited by 19
Mazloumfard, F., Mirian, M., Eftekhari, S.-M., & Aliomrani, M. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00609-z · Cited by 19
“Recent immunology studies demonstrate that T cells, especially T helper type1 (Th1) and T helper type17 (Th17) cells, play an important role in the development of MS (Kebir et al. 2007; Sałkowska et al. 2020).”
BackgroundNanou, A., Bourbouli, M., Vetrano, S., Schaeper, U., Ley, S. C., & Kollias, G. A. (2019) · Cell Reports · doi:10.1016/j.celrep.2021.109168 · Cited by 20
Th17-cells in depression: Implication in multiple sclerosis
Melnikov, M., & Lopatina, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010304 · Cited by 21
Wang, C., Liu, J., Sang, H., Lü, Y., Dong, H., & Xiong, L. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200812020-00019 · Cited by 19
Cross-talk between CD4+ T-cells and neural stem/progenitor cells
Knight, J. C., Hackett, C., Breton, J., & Mao‐Draayer, Y. (2011) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2011.03.030 · Cited by 19
“IL17+ cells have been found in active MS lesions [28], and receptors for Th17 cytokines (IL-17 and IL-22) have been identifiedwithinMS lesions [29].”
BackgroundMiller, N. M., Shriver, L. P., Bodiga, V. L., Ray, A., Basu, S., Ahuja, R., Jana, A., Pahan, K., & Dittel, B. N. (2013) · ASN NEURO · doi:10.1042/an20120087 · Cited by 20
“…demyelination and neuronal damage/loss leading to a variety of neurological deficits (Edwards et al., 2010; Hedegaard et al., 2008; Herz et al., 2009; Kebir et al., 2007; Kornek et al., 2000; Lovett-Racke et al., 2011; Montes et al., 2009; Nylander and Hafler, 2012; Tzartos et al., 2008).”
BackgroundTowards New Therapies for Parkinson's Disease
Finkelstein, D. I. (2011) · InTech eBooks · doi:10.5772/954 · Cited by 19
Marquet, S., Conte, I. L., Poudiougou, B., Argiro, L., Dessein, H., Couturier, C., Burté, F., Oumar, A. A., Brown, B. J., Traore, A., et al. (2017) · Scientific Reports · doi:10.1038/srep41636 · Cited by 20
The RNA-Binding Protein IMP2 Drives a Stromal-Th17 Cell Circuit in Autoimmune Neuroinflammation
Bechara, R., Amatya, N., Majumder, S., Zhou, C., Li, Y., Liu, Q., McGeachy, M. J., & Gaffen, S. L. (2022) · JCI Insight · doi:10.1172/jci.insight.152766 · Cited by 18
“At homeostasis, the Ccl2 gene is transcribed at low tonic levels, but is rapidly induced following exposure to inflammatory stimuli, notably by the encephalogenic cytokine IL-17A (here termed IL-17) (10-12).”
BackgroundThe Significance of the Cell-Mediated Host Immune Response in Syphilis
Kaminiów, K., Kiołbasa, M., & Pastuszczak, M. (2024) · Microorganisms · doi:10.3390/microorganisms12122580 · Cited by 21
Metadata
- Authors
- Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A.
- Affiliations
- University of Zurich (CH)
- Hôpital Notre-Dame (CA)
- University of Alberta (CA)
- Corresponding author
- Prat, Alexandre
- Venue
- Nature Medicine
- Published
- 2007-09-09
- Volume
- 13
- Issue
- 10
- Pages
- 1173-1175
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- PMC
- PMC5114125
- OpenAlex
- W1998000193
- Semantic Scholar
- d0c491686d390e0dfdffedd4e32222d5b6065fd7
- Cited by
- 1,759
- References
- 14
- Citations by year
- 2026: 69 · 2025: 78 · 2024: 85 · 2023: 116 · 2022: 104 · 2021: 86 · 2020: 96 · 2019: 87 · 2018: 98 · 2017: 98 · 2016: 90 · 2015: 94 · 2014: 97 · 2013: 106 · 2012: 86
- FWCI
- 54.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (79785_1)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, blood-brain barrier, endothelial cells, IL-17, IL-22, tight junctions, multiple sclerosis, neuroinflammation, lymphocyte transmigration, granzyme B
- MeSH terms
- Blood-Brain Barrier, Cell Membrane Permeability, Cell Movement, Cells, Cultured, Central Nervous System, Dose-Response Relationship, Drug, Endothelium, Vascular, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Multiple Sclerosis, CD4-Positive T-Lymphocytes, Case-Control Studies, Receptors, Interleukin, Tight Junctions, Interleukin-17, Endothelial Cells, Granzymes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.